Treatment for Adolescents With Depression Study (TADS): Safety Results.
Objective: To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO). Method: Safety assessments included adverse events (AEs) collected by...
| Publicado en: | Journal of the American Academy of Child & Adolescent Psychiatry Vol. 45; no. 12; pp. 1440 - 1456 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Elsevier Science
December 2006
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |